Copertina

Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Zhiheng Yu, Rong Chen, Cheng Zhao, Renwei Zhang, Tianyan Zhou, Yangyu Zhao
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
di: Yongyi Zhang, et al.
Pubblicazione: (2024)

Response to comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
di: Lily Price, et al.
Pubblicazione: (2024)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
di: Wesley D. Kufel, et al.
Pubblicazione: (2025)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
di: Christen J. Arena, et al.
Pubblicazione: (2025)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
di: Nicholas R. Nelson, et al.
Pubblicazione: (2024)

Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study
di: Cornelis F. Vos, et al.
Pubblicazione: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
di: Elmar R. Alizadeh, et al.
Pubblicazione: (2024)

Multicenter study evaluating target attainment of anti‐Factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients
di: Tyler Chanas, et al.
Pubblicazione: (2024)

Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations
di: Aditi Shendre, et al.
Pubblicazione: (2025)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
di: Mennatullah Hasan, et al.
Pubblicazione: (2024)

Fluoroquinolones and the risk of aortic aneurysm or dissection: A population‐based propensity score‐matched German cohort study
di: Julia Wicherski, et al.
Pubblicazione: (2025)

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
di: Mathieu Blouin, et al.
Pubblicazione: (2024)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
di: Nicholas C. Tonial, et al.
Pubblicazione: (2025)

Thirty‐day risk of digoxin toxicity among older adults co‐prescribed trimethoprim‐sulfamethoxazole versus amoxicillin: A population‐based cohort study
di: Flory T. Muanda, et al.
Pubblicazione: (2024)

Correction to “Risk of incident antidepressant‐treated depression associated with use of 5α‐reductase inhibitors compared with use of α‐blockers in men with benign prostatic hyperplasia: A population‐based study using the Clinical Practice Research Datalink”
Pubblicazione: (2024)

Machine Learning‐Based Prediction of Prolonged Duration of Mechanical Ventilation Using Medication Data
di: Brian Murray, et al.
Pubblicazione: (2026)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
di: Seonga Song, et al.
Pubblicazione: (2026)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: Atif Siddiqui
Pubblicazione: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
di: Jiwon Kim, et al.
Pubblicazione: (2025)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
di: Nicolette Centanni, et al.
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
di: Amanda Massmann, et al.
Pubblicazione: (2025)

In Search of Big Beautiful Biomarkers
di: C. Lindsay DeVane
Pubblicazione: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
di: Nihal El Rouby, et al.
Pubblicazione: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
di: Trisha Matsuura, et al.
Pubblicazione: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
di: Amira R. Rashdan, et al.
Pubblicazione: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
di: Kathleen A. Stringer, et al.
Pubblicazione: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
di: Shibing Tao, et al.
Pubblicazione: (2024)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
di: Ashlan J. Kunz Coyne, et al.
Pubblicazione: (2026)

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
di: Jennifer N. Clements, et al.
Pubblicazione: (2026)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
di: Susan E. Smith, et al.
Pubblicazione: (2026)

Issue Information
Pubblicazione: (2026)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
di: Amy Broadwater, et al.
Pubblicazione: (2026)